Abstracts

Inflammation in Acute HIV Infection Correlates With Blood and Gut CD4 T-Cell Loss and Viral Burden

Background: Biomarkers of inflammation, coagulation and fibrosis are associated with morbidity and mortality in HIV infected persons. Understanding the changes in these biomarkers during sequential stages of acute HIV infection (AHI) before seroconversion could illuminate the course of early HIV pathogenesis. Methodology: Plasma levels of D-dimer, hyaluronic acid (HA), C-reactive protein (CRP), soluble CD14 (sCD14),…

CD4 T-Cell Responses in Relationship With Immune Activation and Viral Load in Primary HIV Infectio

Background: Early events during primary HIV infection (PHI) are thought to influence disease outcome. Although few studies have characterized HIVspecific CD4 T cells during PHI, a growing body of evidence suggests a beneficial role of functional CD4 T-cell responses in different aspects of protective immunity in HIV infection. It is unclear how viral replication and…

Herpesvirus Infections in HIV+ Individuals on ART are Not Associated with Immune Activation

Background: We assessed whether systemic reactivation of herpesviruses contributes to innate immune activation and inflammation observed in treated chronic HIV-1 infection. Methodology: We obtained whole blood, plasma, throat washings, urine, semen, and stool specimens from HIV-1(+) MSM in the Multicenter AIDS Cohort Study (MACS) who were 500 cells/mL (HIV+; N=15) as well as in matched,…

Chronic Inflammation in HIV-1 Infected Individuals Reduces T-Cell Responsiveness to Vaccines

Background: Chronic Inflammation remains a problem for HIV-1 infected individuals despite stable anti-retroviral therapy (ART). These low levels of inflammation, an imbalance in the cytokine/chemokine milieu, continue to exacerbate the immune deficiency of HIV+ individuals. And, therefore, these individuals may not mount an adequate immune response to vaccines, such as influenza. Methodology: We assessed the…

Immune activation and risk of HIV-1 transmission among HIV-1 serodiscordant couples

Background: Immune activation is a hallmark of chronic HIV-1 infection. A heightened pro-inflammatory state has been hypothesized to enhance HIV-1 transmission – both susceptibility of HIV-1-exposed persons and infectiousness of HIV-1-infected persons. Methodology: Using data collected prospectively from heterosexual HIV-1 serodiscordant couples from 6 countries in eastern and southern Africa, we conducted a nested case-control…

Persistently Activated CD27+CD80+ B Cells Following ART Correlate With Macrophage Activation

Background: Antiretroviral therapy (ART) and control of HIV replication does not fully restore perturbations within resting (CD19+CD27+CD21+) and activated (CD19+CD27+CD80+) memory B cell compartments. This study was based on the hypothesis that ongoing macrophage activation and HIVassociated inflammation contributes to B cell abnormalities. Methodology: Longitudinal cellular and soluble plasma markers for inflammation were evaluated in…

Interleukin-21 Reduces Residual Immune Activation in ART-treated SIV-infected Rhesus Macaques

Background: Current HIV antiretroviral therapy (ART) successfully inhibits virus replication, improves health, and prolongs life expectancy in people living with HIV. Although HIV replication is suppressed, residual immune activation persists and critically contributes to non-AIDS-related morbidity and mortality in ART-treated individuals. Interleukin (IL)-21 regulates three immunological functions – Th17 cell homeostasis, differentiation of memory B…